3Dhamidharka Va,Kwonc stevens G.a meta.analgsis AM Jkidneg Dis,2002,40(2):221-226.
4National Kidney Foundation. K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation classification, and stratification. Am J Kidney Dis, 2002,39(2suppl) :S1-S266.
5Levey AS, Bosch JP,Levis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med, 1999, 130: 461-470.
6Stevens LA, Coresh J, Greene T, et al. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med,2006,354:2473-2483.
7Vervoort G, Willems HL, Wetzels JF. Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: Validity of a new (MDRD) prediction equation. Nephrol Dial Transplant, 2002,17 : 1909-1913.
8Bostom AG, Kronenberg F, Ritz E. Predictive performance of renal function equations for patients with chronic kidney disease and normal serum creatinine levels. J Am Soc Nephrol, 2002,13 : 2140-2144.
5Thomson BJ, Mcareavey D, Neilsan JM, et al. Heart rate variability and cardiac arrhythmias in patients with chronic renal failure[J]. Clin Auton Res, 2005,1( 2 ): 131-133.
6Stein PK. Heart rate variability and longevity[J]. Am J Cardiol,2010,15(6):910.
7Dharnidharka V R,Kwon C,Stevens G.Serum Cystatin C is superior to serum creatinine as a marker of kidney function:a meta-analysis[J].Am J kidney Dis,2002,40(2):221.
8张之南;沈悌.血液病诊断及疗效标准[M]北京:科学出版社,2007232-234.
9Stevens LA,Coresh J,Schmid CH. Estimating GFR using serum cystatin C alone and in combination with serum creatinine:apooled analysis of 3,418 individuals with CKD[J].American Journal of Kidney Diseases,2008,(03):395-406.doi:10.1053/j.ajkd.2007.11.018.
10Terpos E,Katodritou E,Tsiftsakis E. Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration[J].Haematologica,2009,(03):372-379.
